Hyperfine (HYPR) Share-based Compensation (2021 - 2026)
Hyperfine's (HYPR) quarterly Share-based Compensation came in at $647000.0 in Q1 2026, down 31.53% YoY from $945000.0 in Q1 2025, and down 6.5% on a QoQ basis from $692000.0 in Q4 2025.
Hyperfine (HYPR) Share-based Compensation (2021 - 2026) Analysis & Trends
Hyperfine (HYPR) has 6 years of Share-based Compensation data on file, last reported at $647000.0 in Q1 2026.
- Quarterly Share-based Compensation fell 31.53% year-over-year to $647000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.5 million (down 41.45% YoY) and the FY2025 annual result came in at $2.8 million, down 56.82% from the prior year.
- Share-based Compensation fell to $647000.0 in Q1 2026, from $692000.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $7.1 million in Q2 2022 to a low of -$2.4 million in Q3 2022.
- A 5-year average of $1.4 million and a median of $1.1 million in 2024 frame the typical range for Share-based Compensation.
- The widest YoY moves for Share-based Compensation: up 1439.7% in 2022, down 271.2% in 2022.
- Tracing HYPR's Share-based Compensation over 5 years: stood at $1.8 million in 2022, then dropped by 28.17% to $1.3 million in 2023, then declined by 18.17% to $1.1 million in 2024, then plunged by 34.35% to $692000.0 in 2025, then decreased by 6.5% to $647000.0 in 2026.
- The last three Share-based Compensation figures came in at $647000.0 (Q1 2026), $692000.0 (Q4 2025), and $617000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Hyperfine | 90.12 Mn | 45.35 Mn | 1.98 Mn | 903,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 903,000.00 |
| Jun 30, 2026 | 903,000.00 |
| Mar 31, 2026 | 647,000.00 |
| Mar 31, 2026 | 647,000.00 |
| Dec 31, 2025 | 692,000.00 |
| Dec 31, 2025 | 692,000.00 |
| Sep 30, 2025 | 617,000.00 |
| Sep 30, 2025 | 617,000.00 |
| Jun 30, 2025 | 547,000.00 |
| Jun 30, 2025 | 547,000.00 |
| Mar 31, 2025 | 945,000.00 |
| Mar 31, 2025 | 945,000.00 |
| Dec 31, 2024 | 1.05 Mn |
| Dec 31, 2024 | 1.05 Mn |
| Sep 30, 2024 | 1.10 Mn |
| Sep 30, 2024 | 1.10 Mn |
| Jun 30, 2024 | 1.17 Mn |
| Jun 30, 2024 | 1.17 Mn |
| Mar 31, 2024 | 1.03 Mn |
| Mar 31, 2024 | 1.03 Mn |